New York, April 10, 2015 -- Moody's Investors Service commented that Nellson Nutraceutical, LLC's term loan remains rated B1 following an announced $50 million incremental increase to the term loan. All other ratings remain unchanged and the outlook is stable. Proceeds are being used to partially fund the purchase of assets from NBTY, Inc. Moody's views the asset purchases and new long term supply agreements with NBTY as a credit positive because Moody's expects it to reduce leverage, increase utilization at the company's existing bar manufacturing plants, and diversify operations by providing a second powder plant. For more details please see the Issuer Comment published on April 10, 2015 at www.moodys.com.

Vollständigen Artikel bei Moodys lesen